l******i
发帖数: 14 | 1 现在牛人怎么很大一部分都去药厂了？像Genentech的Morgan Sheng, pfizer的Mike
Ehlers.
很多博士期间做的好的，然后不是太基础的，也基本上去大药厂的研发当group leader
了。
原来学术界基本上毕业，不怎么考虑industry的，现在似乎这个translational
research很火，倒底是什么原因呢？ |
f********n
发帖数: 6465 | |
d*****r
发帖数: 2583 | 3 I think pharm industry has big problem in the future 10-20 years...
better not jump in.
leader
【在 l******i 的大作中提到】
: 现在牛人怎么很大一部分都去药厂了？像Genentech的Morgan Sheng, pfizer的Mike
: Ehlers.
: 很多博士期间做的好的，然后不是太基础的，也基本上去大药厂的研发当group leader
: 了。
: 原来学术界基本上毕业，不怎么考虑industry的，现在似乎这个translational
: research很火，倒底是什么原因呢？
|
O******e
发帖数: 4845 | 4 十几、二十年也太长了吧
【在 d*****r 的大作中提到】
: I think pharm industry has big problem in the future 10-20 years...
: better not jump in.
:
: leader
|
w********u
发帖数: 5457 | 5 zkss
【在 d*****r 的大作中提到】
: I think pharm industry has big problem in the future 10-20 years...
: better not jump in.
:
: leader
|
A******y
发帖数: 2041 | 6 Just wait if they don't produce a drug or two (I think they have less than 5
years). Then you can not even come back to academia. |
x********6
发帖数: 986 | 7 能否具体说说是什么样的问题呢？谢谢！
【在 d*****r 的大作中提到】
: I think pharm industry has big problem in the future 10-20 years...
: better not jump in.
:
: leader
|
A******y
发帖数: 2041 | 8 I think the internal research program in big pharmaceutical companies are
not as productive as people have hoped (I could be wrong and if I am please
give me some examples). A lot of big drug companies survive by buying
successful drugs from smaller company's pipeline today (survival by
acquisition). If this route is cheaper, then having your own large
research facilities just doesn't make any sense, guess what's going to
happen (or already happened).
【在 x********6 的大作中提到】
: 能否具体说说是什么样的问题呢？谢谢！
|
d*****r
发帖数: 2583 | 9 I think the traditional molecule by molecule drug finding approach, or
rationale, is fundamentally flawed. However, the systems approach hasn't
break the bottleneck yet.
So screwed.
please
【在 A******y 的大作中提到】
: I think the internal research program in big pharmaceutical companies are
: not as productive as people have hoped (I could be wrong and if I am please
: give me some examples). A lot of big drug companies survive by buying
: successful drugs from smaller company's pipeline today (survival by
: acquisition). If this route is cheaper, then having your own large
: research facilities just doesn't make any sense, guess what's going to
: happen (or already happened).
|
x********6
发帖数: 986 | 10 Many thanks.
please
【在 A******y 的大作中提到】
: I think the internal research program in big pharmaceutical companies are
: not as productive as people have hoped (I could be wrong and if I am please
: give me some examples). A lot of big drug companies survive by buying
: successful drugs from smaller company's pipeline today (survival by
: acquisition). If this route is cheaper, then having your own large
: research facilities just doesn't make any sense, guess what's going to
: happen (or already happened).
|
|
|
m*****i
发帖数: 628 | 11 buying small company does not help either.
please
【在 A******y 的大作中提到】
: I think the internal research program in big pharmaceutical companies are
: not as productive as people have hoped (I could be wrong and if I am please
: give me some examples). A lot of big drug companies survive by buying
: successful drugs from smaller company's pipeline today (survival by
: acquisition). If this route is cheaper, then having your own large
: research facilities just doesn't make any sense, guess what's going to
: happen (or already happened).
|
w***u
发帖数: 17713 | 12 大药厂问题大着呢。养了上万博士，几年下不来一个药，全靠收购些几十个人的小
biotech撑着。大企业病，养博士教授再多也是废物。也就靠着以前的专利，和漂亮女
药物代表养人。 |
m*****i
发帖数: 628 | 13 漂亮固然好。回扣才是硬道理。
收购小biotech已经没有用了。吃别的大pharma才能续命几年。
【在 w***u 的大作中提到】
: 大药厂问题大着呢。养了上万博士，几年下不来一个药，全靠收购些几十个人的小
: biotech撑着。大企业病，养博士教授再多也是废物。也就靠着以前的专利，和漂亮女
: 药物代表养人。
|
p*****m
发帖数: 7030 | 14 Vishva Dixit, Marc Tessier-Lavigne, Mark Fishman, En Li,Don Ganem, 更不要说曾
经如雷贯耳的roche institute of molecular biology
大药厂就喜欢弄学术牛人去给R&D撑门面呗 用处应该是基本没有的
leader
【在 l******i 的大作中提到】
: 现在牛人怎么很大一部分都去药厂了？像Genentech的Morgan Sheng, pfizer的Mike
: Ehlers.
: 很多博士期间做的好的，然后不是太基础的，也基本上去大药厂的研发当group leader
: 了。
: 原来学术界基本上毕业，不怎么考虑industry的，现在似乎这个translational
: research很火，倒底是什么原因呢？
|
j****x
发帖数: 1704 | 15 呵呵，可惜现在大部分都撑不住然后散伙了
说曾
【在 p*****m 的大作中提到】
: Vishva Dixit, Marc Tessier-Lavigne, Mark Fishman, En Li,Don Ganem, 更不要说曾
: 经如雷贯耳的roche institute of molecular biology
: 大药厂就喜欢弄学术牛人去给R&D撑门面呗 用处应该是基本没有的
:
: leader
|
p*****m
发帖数: 7030 | 16 我说的这些个基本都还在啊 除了Marc
Roche institute很可惜的 要是现在还在我决然要去那儿找工作
【在 j****x 的大作中提到】
: 呵呵，可惜现在大部分都撑不住然后散伙了
:
: 说曾
|
p*******r
发帖数: 4048 | 17 Mostly I think they will move all research to China.
I was just in UK. GSK is shutting down almost everything there and move to
Shanghai.
please
【在 A******y 的大作中提到】
: I think the internal research program in big pharmaceutical companies are
: not as productive as people have hoped (I could be wrong and if I am please
: give me some examples). A lot of big drug companies survive by buying
: successful drugs from smaller company's pipeline today (survival by
: acquisition). If this route is cheaper, then having your own large
: research facilities just doesn't make any sense, guess what's going to
: happen (or already happened).
|
y***i
发帖数: 11639 | 18 How about India? Is India competitive attracting pharmaceutical research?
are
【在 p*******r 的大作中提到】
: Mostly I think they will move all research to China.
: I was just in UK. GSK is shutting down almost everything there and move to
: Shanghai.
:
: please
|
n********r
发帖数: 195 | 19 all research to China? You must be kidding. If a company move all research
to China, stock market will lose interest in it. The company is close to
bankrupt. It might also have trouble filing appplication to FDA
【在 p*******r 的大作中提到】
: Mostly I think they will move all research to China.
: I was just in UK. GSK is shutting down almost everything there and move to
: Shanghai.
:
: please
|
n********r
发帖数: 195 | 20 The stuff from india is junk. Couple years later, like IT industry, drug
maker will realize outsource everything to india is not a good idea. They
are cheap and can save money, but the quality is more important.
research?
【在 y***i 的大作中提到】
: How about India? Is India competitive attracting pharmaceutical research?
:
: are
|
|
|
z*t
发帖数: 863 | 21 个人觉得，En Li在norvatis有点小扯，他是甲基化与ES cell方向的牛人，但是去了
norvatis还是在做dnmt相关的基础项目。除了08年的Dnmt1 KO有点实际应用的方向外。
而不是想steve baylin和peter jones在真正push DNMT inhibitor的translational
research.
现在他回去后又在玩MeCP2,想在脑中一半表达mutant MeCP2的neuron中activate那份携
带正常copy但被slience掉得 X chromosome。
anyway,他在美国一个postdoc在做epigenetics的drug,据说有上到phase II,不知后续
如何哈。
说曾
【在 p*****m 的大作中提到】
: Vishva Dixit, Marc Tessier-Lavigne, Mark Fishman, En Li,Don Ganem, 更不要说曾
: 经如雷贯耳的roche institute of molecular biology
: 大药厂就喜欢弄学术牛人去给R&D撑门面呗 用处应该是基本没有的
:
: leader
|
l******i
发帖数: 14 | 22 我觉的如果自己在学术界的research能够有什么好的发现，然后对drug discovery感兴
趣的话，就可以考虑带自己的drug target过去做，这是很好的一个选择。 当然了，如
果还是真心喜欢做学术的话，就再说了。 |
p*******r
发帖数: 4048 | 23 Not all research in the company, just that particular site.
They moved some of those staff to US as well.
I am just pointing out a trend.
【在 n********r 的大作中提到】
: all research to China? You must be kidding. If a company move all research
: to China, stock market will lose interest in it. The company is close to
: bankrupt. It might also have trouble filing appplication to FDA
|
